首页|天舒片联合盐酸氟桂利嗪胶囊治疗偏头痛患者的效果

天舒片联合盐酸氟桂利嗪胶囊治疗偏头痛患者的效果

扫码查看
目的:观察天舒片联合盐酸氟桂利嗪胶囊治疗偏头痛患者的效果.方法:选取 2020 年 3 月至 2022 年 3 月该院收治的76 例偏头痛患者进行前瞻性研究,按照随机数字表法分为研究组与对照组各 38 例.对照组采用盐酸氟桂利嗪胶囊治疗,研究组在对照组基础上联合天舒片治疗,比较两组治疗总有效率,偏头痛发作频率、每次发作持续时间、发作时视觉模拟评分法(VAS)评分,血清细胞因子[白细胞介素增强结合因子-1(ILF-1)、降钙素基因相关肽(CGRP)、内皮素-1(ET-1)]水平和不良反应发生率.结果:研究组治疗总有效率为 94.74%,明显高于对照组的 76.32%,差异有统计学意义(P<0.05);治疗后,两组偏头痛发作频率和VAS评分均低于治疗前,且研究组低于对照组,两组每次发作持续时间均短于治疗前,且研究组短于对照组,差异有统计学意义(P<0.05);治疗后,两组血清CGRP水平高于治疗前,且研究组高于对照组,两组血清ET-1、ILF-1 水平低于治疗前,且研究组低于对照组,差异均有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:天舒片联合盐酸氟桂利嗪胶囊治疗偏头痛患者可提高治疗总有效率,缩短每次发作持续时间,改善血清细胞因子水平,降低偏头痛发作频率和VAS评分,效果优于单纯盐酸氟桂利嗪胶囊治疗.
Effects of Tianshu tablets combined with Flunarizine hydrochloride capsules in treatment of migraine patients
Objective:To observe effects of Tianshu tablets combined with Flunarizine hydrochloride capsules in treatment of migraine patients.Methods:A prospective study was conducted on 76 patients with migraine admitted to the hospital from March 2020 to March 2022.According to the random number table method,they were divided into study group and control group,38 cases in each group.The control group was treated with Flunarizine hydrochloride capsules,while the study group was treated with Tianshu tablets on the basis of that of the control group.The total effective rate of treatment,the migraine attack frequency,the duration of each attack,the visual analogue scale(VAS)score during attack,the serum cytokines[interleukin enhancer binding factor-1(ILF-1),calcitonin gene-related peptide(CGRP),endothelin-1(ET-1)]levels,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the study group was 94.74%,which was significantly higher than 76.32%of the control group,and the difference was statistically significant(P<0.05).After the treatment,the migraine attack frequencies and the VAS scores in the two groups were lower than those before the treatment,and those in the study group were lower than those in the control group;the duration of each attack in the two groups were shorter than those before the treatment,and that in the study group was shorter than that in the control group;and the differences were statistically significant(P<0.05).After the treatment,the levels of serum CGRP the two groups were higher than those before the treatment,and that in the study group was higher than that in the control group;the levels of serum ET-1 and ILF-1 in the two groups were lower than those before the treatment,and those in the study group were lower than those in the control group;and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Tianshu tablets combined with Flunarizine hydrochloride capsules can improve the total effective rate,shorten the duration of each attack,improve the levels of serum cytokines,and reduce the migraine attack frequency and the VAS scores in the treatment of the migraine patients.Moreover,it is superior to single Flunarizine hydrochloride capsules treatment.

Tianshu tabletsFlunarizine hydrochlorideMigraineCytokineVAS scoreAdverse reaction

常国宁、康进忠、郭严

展开 >

安阳市中医院脑病三科,河南 安阳 455000

天舒片 盐酸氟桂利嗪 偏头痛 细胞因子 视觉模拟评分 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(5)
  • 10